Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nano LIFE is Scopus-indexed (Q2, CiteScore 2.3), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by World Scientific.
Checked against the index lists dated .
ISSN 1793-9844Verify ISSN ↗1793-9852Verify ISSN ↗
Publisher: World Scientific
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 230 / 466 | 50th | Q2 |
| Pharmaceutical Science | 112 / 191 | 41st | Q3 |
| Biomedical Engineering | 241 / 342 | 29th | Q3 |
| Bioengineering | 138 / 168 | 18th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2014 (also 2022–present), best quartile Q2, CiteScore 2.3.
Nano LIFE is Q2 in Medicine (miscellaneous) (rank 230 of 466), Q3 in Pharmaceutical Science (rank 112 of 191) and Q3 in Biomedical Engineering (rank 241 of 342), by CiteScore 2025. It is ranked in 4 subject areas in all.
Nano LIFE is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q2 at the 50th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.216, quartile Q3, with an H-index of 6.
Nano LIFE is published by World Scientific. Its print ISSN is 1793-9844 and its online ISSN is 1793-9852.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nano LIFE has an h-index of 25 and a 2-year mean of 2.38 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q2. On 2-year citations it ranks #138 of 451 Scopus journals in Medicine (miscellaneous).
Nano LIFE published 52 papers in 2025; its busiest recent year was 2024 with 53. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 96 research articles (2024–2026), authors are most often from India (36.1%), Bangladesh (11.5%) and Iraq (11%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.